Titre:
  • Neoadjuvant anthracycline and trastuzumab for breast cancer: is concurrent treatment safe?
Auteur:Bozovic, Ivana; Abdel Azim, Hatem Hamdy; Paesmans, Marianne; Suter, Thomas; Piccart-Gebhart, Martine; Azambuja, Evandro
Informations sur la publication:Lancet oncology, 12, 3, page (209-211)
Statut de publication:Publié, 2011-03
Sujet CREF:Cancérologie
MeSH keywords:Anthracyclines -- administration & dosage
Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Agents -- administration & dosage
Breast Neoplasms -- drug therapy -- metabolism
Drug Therapy, Combination
Female
Humans
Neoadjuvant Therapy
Receptor, erbB-2
Note générale:Journal Article
SCOPUS: le.j
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(11)70013-4
info:pii/S1470-2045(11)70013-4
info:scp/79952043612
info:pmid/21354372